Company Data
BioVie Inc.
Ticker
BIVI
Current Price
$1.48 -9.2%
Market Cap
$27.3M
Price Target
Refer to Report
Volume
595.2K
52wk Range
$1.0404 - $33.1
Overview
BioVie Inc is a company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is currently focused on developing and commercializing BIV201, a novel investigational approach to the treatment of ascites due to chronic liver cirrhosis. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.